Energy Metabolism & Diseases of Modern Civilization: Part II: Pathophysiology Johannes Klein, University of Lübeck, Germany.
test
Metabolic syndrome
DMC_2009_Diabetes_an..
Brian Covello: Diabetes Research Paper
Pyrrolotriazines as Novel Potent ALK Inhibitors
What Causes Microvascular and Macrovascular Complications in Patients with Type 2 Diabetes? Charles A. Reasner, MD Professor of Medicine University of.
TOR ( target of rapamycin) signaling Apr 4, 2005.
Diabetes mellitus. Introduction It is a clinical syndrome characterized by disturbance in carbohydrates, fat, & proteins metabolism due to either insulin.
3 rd Annual Friedman Fellows Symposium November 13 th 2010 Pauline Suwandhi, M.D., Amit Seth, M.D., Ashutosh Pareek, D.O., Vanessa Sy, M.D., Leonid Poretsky,
